Klinické štúdie Migréna v štáte Utah
7 štúdií pre Migréna hľadá účastníkov v zariadeniach v štáte Utah.
Mestá v štáte Utah
Oficiálny text štúdie (anglicky)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Pantheon Clinical Research /ID# 270259, Bountiful
- Alpine Research Organization - Clinton /ID# 276527, Clinton
- Highland Clinical Research /ID# 270281, Salt Lake City
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Advanced Research Institute Ogden, Ogden
Prebieha náborFáza 4
Vek 18 až 70 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pantheon Clinical Research /ID# 250703, Bountiful
- Highland Clinical Research /ID# 239362, Salt Lake City
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Highland Research, Salt Lake City
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Pantheon Clinical Research, Bountiful
- J. Lewis Research, Inc. / Foothill Family Clinic Draper, Draper
- Advanced Research Institute, Ogden
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07645924Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.